Welcome to our dedicated page for Global Medical SEC filings (Ticker: GMRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lease escalators, tenant credit metrics, and reimbursement risks often hide deep inside Global Medical REIT Inc. (GMRE) disclosures—details that can make or break a dividend thesis. If you have ever searched for “Global Medical REIT insider trading Form 4 transactions” or wondered where last quarter’s rent coverage ratios are buried, you know the challenge.
Stock Titan solves that problem. Our AI reads every 10-K, 10-Q, 8-K, and DEF 14A the moment it hits EDGAR, then delivers plain-language explanations. Think “Global Medical REIT annual report 10-K simplified” or “Global Medical REIT quarterly earnings report 10-Q filing decoded”. Key numbers—cash NOI, weighted-average lease term, dividend payout ratio—are surfaced so you can focus on decisions, not page counts.
Need real-time alerts? Form 4 insider data streams in seconds, giving you “Global Medical REIT Form 4 insider transactions real-time” visibility into executive stock moves. Our dashboard also links each “Global Medical REIT proxy statement executive compensation” to historical pay trends and flags any outsized awards. Material events? “Global Medical REIT 8-K material events explained” stories summarize new acquisitions or lease amendments in a paragraph.
- Track acquisition cap rates across filings with AI-powered summaries
- Compare quarter-over-quarter rental revenue without wading through tables
- Monitor “Global Medical REIT earnings report filing analysis” minutes after release
Whether you’re a yield-focused investor or an analyst modeling tenant coverage, understanding Global Medical REIT SEC documents with AI lets you act faster and with greater confidence.
Global Medical REIT Inc. amended its credit facilities to extend maturities and reprice a spread adjustment. The $400M revolver maturity is extended to
Global Medical REIT Inc. director Matthew Cypher purchased 1,350 shares of the company's common stock on 08/26/2025 at a price of $7.3781 per share. After the transaction he beneficially owns 1,350 shares, held directly. The Form 4 was signed by an attorney-in-fact, Jamie Barber, on the same date.
Jamie Allen Barber, who serves as General Counsel and Secretary and is identified as a director, reported the sale of 130,000 shares of Global Medical REIT Inc. (GMRE) on 08/15/2025. The Form 4 shows the shares were sold at a weighted average price of $6.6236 (individual trade prices ranged from $6.50 to $6.74). Following the reported transactions the filing indicates 0 shares beneficially owned by the reporting person. The form was signed on 08/18/2025 and was filed by one reporting person.
Global Medical REIT Inc. (GMRE) director and CEO Mark O. Decker Jr. reported purchases of common stock on 08/15/2025: 13,871 shares at $6.84 (direct), and 17,023 shares at $6.87 (indirect via spouse). After these transactions he beneficially owned 173,871 shares directly and 190,894 shares indirectly.
Global Medical REIT Inc. (GMRE) Form 144: This notice reports a proposed sale of 130,000 common shares, with an aggregate market value of $878,000.00. The shares were acquired on 08/07/2025 as a stock award from the issuer and paid as compensation. The filer lists Fidelity Brokerage Services LLC (245 Summer Street, Boston MA) as the broker and identifies an approximate sale date of 08/15/2025 on the NYSE. The issuer's reported number of shares outstanding is 66,878,728. The filing states there were no securities sold in the past three months by the person for whose account the securities will be sold. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Jamie Barber, who serves as General Counsel and Secretary and is a director of Global Medical REIT Inc. (GMRE), converted 130,000 long-term incentive plan units (LTIP Units) in the operating partnership into OP Units and had those OP Units redeemed for an equal number of the issuer's common shares. As a result, Barber directly beneficially owns 130,000 shares of GMRE common stock following the transaction. The filing states LTIP Units were issued under the 2016 Equity Incentive Plan and have no expiration date, and OP Units may be redeemed for cash or, at the issuer's election, for one-for-one shares of common stock.
GMRE’s Q2 2025 10-Q shows modest top-line growth offset by higher financing costs. Rental revenue rose 10.7% YoY to $37.9 m, lifting total revenue to $38.0 m. Operating expense inflation (+13%) and an 15% jump in interest expense limited operating income to $0.4 m (vs. $1.4 m LY). Net income turned positive at $0.6 m, yet after $1.5 m preferred dividends common shareholders posted a $0.8 m loss (-$0.01/sh).
Balance sheet leverage increased. Net real-estate investment grew $42 m to $1.20 b after acquiring five facilities for $79.7 m and selling three for $9.1 m gains. Credit-facility borrowings expanded $67 m to $699 m, pushing total liabilities to $772 m (+10%). Equity fell 6% to $525 m, driven by dividend distributions and an $8.2 m OCI hit from falling swap values. Cash flow from operations covered common and preferred dividends ($34.4 m OCF vs. $33.4 m payouts). Management flags $24.6 m of committed cap-ex (≈$12.6 m in next 12 mo).
Key trends: 1) revenue growth from acquisitions continues; 2) elevated debt and rising SOFR expose earnings to rate risk despite hedges; 3) dividend remains higher than GAAP earnings but covered by FFO proxy cash flow; 4) active capital recycling—three small Q1-Q2 sales and a 12.5% JV stake launched in late-2024.
Global Medical REIT (NYSE:GMRE) Form 4 discloses that newly appointed CEO and President Mark Okey Decker Jr. purchased 160,000 common shares on 24-25 June 2025 at a weighted average price of about $6.52, committing roughly $1.0 million of personal capital. Following the transactions, he directly owns 160,000 shares.
On 23 June 2025 he also received 158,730 Long-Term Incentive Plan (LTIP) units, exchangeable one-for-one for common stock after vesting on the third anniversary of grant.
- Transaction code: P (open-market purchases)
- Ownership form: Direct
- No Rule 10b5-1 plan indicated
The >$1 million insider buy by the CEO is a potentially positive signal of management confidence and tighter alignment with shareholder interests.
FAQ
What is the current stock price of Global Medical (GMRE)?
What is the market cap of Global Medical (GMRE)?
